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Weight loss in cancer patients is a worrisome constitutional change predicting disease progression 
and shortened survival time. A logical approach to counter some of the weight loss is to provide 
nutritional support, administered through enteral nutrition (EN) or parenteral nutrition (PN). The 
aim of this paper was to update the original systematic review and meta-analysis previously 
published by Chow et al, while also assessing publication quality and effect of RCTs on the meta-
conclusion over time. 
Methods 
A literature search was carried out; screening was conducted for randomized controlled trials 
published in January 2015 up until December 2018. The primary endpoints were the percentage 
of patients achieving no infection and no nutrition support complications. Secondary endpoints 
included proportion of patients achieving no major complications and no mortality. Review 
Manager (RevMan 5.3) by Cochrane IMS and Comprehensive Meta-Analysis (Version 3) by 
Biostat were used for meta-analyses of endpoints and assessment of publication quality. 
Results 
An additional 7 studies were identified since our prior publication, leading to 43 papers included 
in our review. The results echo those previously published; EN and PN are equivalent in all 
endpoints except for infection. Subgroup analyses of studies only containing adults indicate 
identical risks across all endpoints. Cumulative meta-analysis suggests that meta-conclusions have 
remained the same since the beginning of publication time for all endpoints except for the endpoint 
of infection, which changed from not favouring to favouring EN after studies published in 1997. 
There was low risk of bias, as determined by assessment tool and visual inspection of funnel plots. 
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Conclusions 
The results support the current European Society of Clinical Nutrition and Metabolism (ESPEN) 
guidelines recommending enteral over parenteral nutrition, when oral nutrition is inadequate, in 
adult patients. Further studies comparing EN and PN for these critical endpoints appear 
unnecessary, given the lack of change in meta-conclusion and low publication bias over the past 
decades. 
 
Keywords: parenteral nutrition (PN), enteral nutrition (EN), cancer patients, malnutrition, tube 
feeding (TF), standard care (SC) 
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INTRODUCTION 
Unintentional weight loss for cancer patients is a worrisome constitutional change predicting 
disease progression and shortened survival time [1-2]. A logical approach to counter weight loss 
is to provide nutritional support, administered through enteral nutrition (EN) or parenteral nutrition 
(PN) [3-4]. Historically, these approaches are accompanied with concerns of increased 
complications and costs; EN may hence be the preferred modality, due to its lower costs, fewer 
complications, and perceived better outcomes [4-6]. Over the past several decades, however, there 
have been substantial changes in clinical nutrition – the cost effectiveness of nutrition support has 
significantly increased through adoption of “all-in-one bags” for parenteral nutrition, novel enteral 
and parenteral formulas, peripheral insertion, and new materials for venous and enteral accesses, 
just to name a few [7]. New strategies, including standardized “bundles” of evidence-based 
interventions and strict policies of antisepsis, have also been developed and implemented to reduce 
the risk of complications [7].  
 The first meta-analysis comparing complication rates of EN and PN in cancer patients was 
published in 2016 [7], and looked at endpoints of infection, nutrition support complications, major 
complications and mortality. It included 36 articles [8-43], and reported that similar rates of 
nutrition support complications, major complications and mortality were observed between 
patients receiving EN and PN. Infection rates were reported to be slightly higher among PN 
patients.  
 Since the original review, more trials have been published and additional information has 
the potential for a more comprehensive meta-analysis with greater confidence in the principle 
conclusions. Moreover, the original review did not assess publication quality, or quantitatively 
assess for publication bias. With over 1,000 patients randomized to EN and PN each, the current 
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meta-analysis may be sufficiently powered to offer a precise point estimate and recommend trial 
resources be dedicated elsewhere. To determine the effect of the latest randomized controlled trials 
(RCTs), a cumulative meta-analysis may adequately assess the meta-conclusion over time, as 
RCTs with new data are published.  
 The aim of this paper was to compare complication rates for EN and PN cancer patients, 
through updating the systematic review and meta-analysis previously published, while also 




A literature search was carried out in Ovid MEDLINE, Embase Classic and Embase, and Cochrane 
Central Register of Controlled Trials. The search included studies up until the last week of 
December 2018 and was limited to English-language studies and RCTs. Search terms included 
“PN”, “EN” and “comparative studies” [Appendix 1], similar to the prior review by Chow et al 
[7]. Reference lists of included studies were also included in the search. 
 
Selection Criteria 
Screening was conducted by two authors (RC, LC); where disagreement occurred, discussion and 
consensus was achieved with input from a third author (NC); Cohen’s kappa coefficient 
documented the inter-rater agreement. Titles and abstracts published after January 2015 and 
beyond were screened and deemed relevant for full-text review if there was mention of parenteral 
nutrition and enteral nutrition, and additionally stated that the two nutrition support treatments 
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were compared. Following full-text review, studies were included if over 50% of the study 
population had any form and any stage of cancer, in line with the prior review by Chow et al [7].  
 
Endpoints 
The primary endpoints were the percentage of patients achieving no infection and no nutrition 
support complications. Secondary endpoints included proportion of patients achieving no major 
complications and no mortality.  
 The definition of endpoints is the same as those reported by the former review published 
by Chow et al. [7]. Minor infections were recorded as reported in studies; when studies provided 
a breakdown of infection complications, the endpoint “minor infections” was the summation of 
wound infection, pneumonia and sepsis. Nutrition support complications were recorded as 
published in studies, or reported as the summation of nausea, vomiting and diarrhea events. Major 
complication events included major complications and morbidity are reported, as disclosed in 
studies. Mortality rate was noted as they were recorded in literature. 
 Additional study characteristics recorded include type of EN (standard care (SC) and tube 
feeding (TF)), nutrition status of population (including individuals who are malnourished or 
deemed with protein-energy malnutrition (PEM); studies not mentioning PEM were assumed to 
have no malnourished patients as we postulated that this demographic would be reported if PEM 
patients were prevalent) and age of population (children as defined by study, typically 21 years 
and younger, or adults). 
 
Statistical Analysis 
March 25, 2019 
This is a post-peer-review, pre-copyedit version of an article published in Supportive Care in Cancer.  
The final authenticated version is available online at: https://doi.org/10.1007/s00520-019-05145-w 
 
- 7 - 
 
The Mantel-Haenszel model was applied and a random effects analysis model was used to generate 
risk ratios (RR) and their accompanying 95% confidence intervals (CIs). A p-value of less than 
0.05 was deemed statistically significant in the test for overall effect; a heterogeneity test with p-
value greater than 0.05 was considered suitable. For all endpoints, we used the number of patients 
that did not experience the outcomes as the event numbers, to enable calculation of risks and risk 
ratios. Test for heterogeneity was conducted to determine whether the size of the effect was equal 
in all included studies. Review Manager (RevMan 5.3) by Cochrane IMS was used for the 
aforementioned analyses, to update the previously published analyses and forest plots. 
Comprehensive Meta-Analysis (Version 3) by Biostat was also used to conduct a cumulative meta-
analysis, and assess the effect of studies to the meta-conclusion over publication time.  
 
Assessment of Publication Quality 
Funnel plots were generated by Review Manager (RevMan 5.3) to visually assess for publication 




A total of 216 titles and abstracts were screened, of which 60 were identified for full-text screening 
(Cohen’s kappa = 0.9239). The updated search yielded 7 additional studies [44-50] for inclusion 
in this systematic review and meta-analysis (Cohen’s kappa = 0.7931) [Appendix 2]. The studies 
all reported on TF and studied adults. The study by Harvey et al. [46] included patients classified 
as PEM. 
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Infection 
PN was slightly statistically superior with respect to infection (RR = 1.11; 95% CI: 1.04-1.19). 
Subgroup analyses by EN indicated that TF is superior to PN, whereas SC is equivalent. In patients 
suffering from PEM, PN and EN are equivalent. A higher risk of infection was noted among adult 
studies; no greater risk was reported among studies in children [Figure 1]. The aforementioned 
meta-conclusion, favouring PN, has remained unchanged since 1997; the cumulative RR remains 
in favour of PN with the inclusion of each published study dating to 1997 [Figure 2]. 
 
Nutrition Support Complications 
Risk of nutrition support complications in EN and PN patients were equivalent (RR = 1.00; 95% 
CI: 0.96-1.05). Subgroup analyses by modality of EN, nutrition status and age of population reveal 
that the rate of complications is equivalent within subgroups too [Figure 3]. Since the first study, 
the meta-conclusion has not favoured EN or PN [Figure 4]. 
 
Major Complications 
Neither EN nor PN were superior with respect to lower incidence of major complications. No 
studies on children reported on this endpoint. Subgroup analyses of TF, SC, PEM studies and non-
PEM studies reported a similar conclusion [Figure 5]. The meta-conclusion has remained the same 
since the first publications [Figure 6]. 
 
Mortality 
Analyses and subgroup analyses indicate equivalent mortality rates between EN and PN [Figure 
7]. The meta-conclusion over time has remained the same [Figure 8]. 
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Unsuitable levels of heterogeneity were observed for all analyses of the endpoint “No infection”, 
except for subgroup analyses of studies reporting on children [Figure 1]. Subgroup analyses of 
“No nutrition support complications” of subgroup SC, non-PEM studies, and child studies had 
appropriate levels of heterogeneity; other analyses of this endpoint have unsuitable levels [Figure 
3]. These unsatisfactory levels may be a consequence of different clinical methodologies, such as 
different definitions of endpoints across different studies. All analyses of “No major 
complications” except for subgroup analyses of SC had satisfactory heterogeneity [Figure 5]. 
Satisfactory levels were observed for all analyses of endpoint “No mortality” [Figure 7]. 
 
Publication Quality 
The majority of studies had low risk of bias [Appendix 3]. No obvious publication biases exist, as 
noted by lack of glaring asymmetries upon visual inspection of funnel plots [Appendices 4-7]. 
 
DISCUSSION 
This systematic review and meta-analysis comparing complication rates between cancer patients 
administered EN or PN includes 43 studies, which is the highest-powered analysis to date in the 
cancer setting: the original meta-analysis by Chow et al. in 2016 comprised of 36 studies, while 
Braunschweig et al.’s study in 2001 had only 7 studies in their subgroup analyses of cancer patients 
[51]. The results in this study echo those published in 2016; EN and PN are equivalent in all 
endpoints except for infection [7]. In fact, cumulative meta-analysis suggests that meta-
conclusions have remained the same since the beginning of publication time (i.e. the first published 
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RCT) for all endpoints except for the endpoint of infection, which changed from not favouring to 
favouring EN after studies published in 1997. 
 Compared to the original review, this review involved additional analyses. The prior 
review conducted subgroup analyses only by type of EN and nutrition status; this review also 
investigated endpoints by age of the study population. For studies containing children, PN was 
equivalent to EN in all three endpoints – infection, nutrition support complications, and mortality; 
no studies reported on major complications/morbidity. In adults, the conclusion remains 
unchanged: EN is superior to PN only in infection. These results hence support the current 
European Society of Clinical Nutrition and Metabolism (ESPEN) guidelines that suggests enteral 
over parenteral where the gastrointestinal tract works, when oral nutrition is inadequate [52]. 
 Lack of bias, as assessed by the Cochrane Risk of Bias assessment tool and through visual 
inspection of funnel plots, suggests that the existing literature appropriately documents critical 
endpoints of PN compared to EN; RCTs, in line with the nature of their study type, did not have 
critical methodology flaws/biases. This, when considered in conjunction with the results of the 
cumulative meta-analyses examining studies over the past two decades has only refined our point 
estimate and has not altered our meta-conclusion, suggests that no new trials are required in this 
setting to look into these critical endpoints. When considering whether a cancer patient should be 
administered EN or PN, other considerations should be pondered. 
 PN has been reported to require less time in improving a patient’s nutritional state, which 
can minimize hospital stays and help expedite turnover of hospital beds to care for more patients 
[43]. However, EN is nearly half the cost of PN, and may be more fiscally favourable [20]. PN has 
also been reported to be more beneficial for cancer surgery patients; PN may continue 
uninterrupted during settings where oral feeding may need to be withheld, such as during some 
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preoperative diagnostic procedures [13]. However, the results of this meta-analysis suggest that 
risk of major complications/morbidity and mortality of both nutrition support routes are still 
equivalent.  
 This review has its limitations. The reporting of endpoints across studies was not 
standardized: different definitions and recording methods for infections, nutrition support 
complications, and major complication outcomes existed. To accurately capture and extract 
endpoints, we reviewed and contacted corresponding authors when necessary for clarification of 
endpoints and collection of more data. Overall risk ratios computed by cumulative meta-analyses 
and standard meta-analysis forest plots differed slightly, due to rounding. Assessment of 
publication bias via funnel plots did not include accompanying quantitative metrics such as 
Egger’s test; the lack of asymmetry, however, clearly indicates no publication bias. 
 This systematic review reaffirms the conclusions originally reported by the meta-analysis 
by Chow et al: that neither PN nor EN are superior for all endpoints (major complications, 
mortality, nutrition support complications) other than infection. Cumulative meta-analyses, in fact, 
indicate that the meta-conclusion has not changed for several decades; new trials investigating 
these endpoints are likely unnecessary as they would add little value to the existing body of 
literature. Subgroup analyses of studies only containing adult patients show no superiority of PN 
compared to EN, supporting ESPEN’s latest guidelines recommending EN should be provided for 
cancer patients where oral intake is inadequate or they are already malnourished, given that their 
gastrointestinal tract is functional.  
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Figure 1. No infection for enteral nutrition (EN) and parenteral nutrition (PN) patients 1.1 
Analyses by EN – tube feeding and standard care 1.2 Analyses by nutrition status – protein energy 
malnutrition (PEM) and no PEM 1.3 Analyses by age of population – children and adults 
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Figure 2. No infection for enteral (EN) and parenteral nutrition (PN) patients, over time 
  
Study name Cumulative statistics Cumulative mh risk ratio (95% CI)
Lower Upper 
Point limit limit Z-Value p-Value
Holter et al 1977 1.030 0.754 1.407 0.187 0.851
van Eys et al 1980 1.145 0.854 1.536 0.907 0.365
Thompson et al 1981 1.121 0.865 1.453 0.862 0.389
Sako et al 1981 1.054 0.863 1.288 0.516 0.606
Lim et al 1981 1.050 0.866 1.275 0.498 0.619
Muller et al 1982 1.013 0.845 1.215 0.144 0.886
van Eys et al 1982 1.030 0.873 1.216 0.355 0.723
Hays et al 1983 1.050 0.893 1.234 0.587 0.557
Hamaoui et al 1990 1.031 0.888 1.197 0.396 0.692
Von Meyenfeldt et al 1992 1.065 0.919 1.233 0.836 0.403
Sandstrom et al 1993 1.123 0.980 1.287 1.664 0.096
Iovinelli et al 1993 1.103 0.970 1.255 1.490 0.136
Brennan et al 1994 1.134 1.002 1.284 1.984 0.047
Shirabe et al 1997 1.156 1.023 1.307 2.322 0.020
Sand et al 1997 1.154 1.024 1.301 2.356 0.018
Reynolds et al 1997 1.172 1.043 1.317 2.675 0.007
Bozzetti et al 2001 1.169 1.049 1.304 2.812 0.005
Pacelli et al 2001 1.142 1.031 1.265 2.551 0.011
Aiko et al 2003 1.132 1.025 1.250 2.437 0.015
Kamei et al 2005 1.117 1.015 1.228 2.276 0.023
Schmid et al 2006 1.124 1.023 1.235 2.433 0.015
Seike et al 2011 1.118 1.019 1.228 2.349 0.019
Liu et al 2011 1.111 1.016 1.215 2.309 0.021
Park et al 2012 1.099 1.008 1.199 2.140 0.032
Fujita et al 2012 1.097 1.009 1.193 2.169 0.030
Boelens et al 2014 1.107 1.020 1.202 2.422 0.015
Klek et al 2014 1.096 1.012 1.187 2.248 0.025
Huang et al 2015 1.105 1.022 1.195 2.501 0.012
Perinel et al 2016 1.102 1.021 1.190 2.490 0.013
Luo et al 2017 1.099 1.020 1.183 2.482 0.013
Chen et al 2017 1.111 1.033 1.196 2.830 0.005
Wang et al 2018 1.118 1.041 1.200 3.057 0.002
1.118 1.041 1.200 3.057 0.002
0.5 1 2
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Figure 3. No nutrition support complications for enteral nutrition (EN) and parenteral nutrition 
(PN) patients 3.1 Analyses by EN – tube feeding and standard care 3.2 Analyses by nutrition status 
– protein energy malnutrition (PEM) and no PEM 3.3 Analyses by age of population – children 
and adults 
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Figure 4. No nutrition support complications for enteral (EN) and parenteral nutrition (PN) 
patients, over time 
  
Study name Cumulative statistics Cumulative mh risk ratio (95% CI)
Lower Upper 
Point limit limit Z-Value p-Value
Thompson et al 1980 1.074 0.797 1.446 0.469 0.639
Sako et al 1981 1.062 0.901 1.252 0.715 0.475
Lim et al 1981 1.068 0.926 1.232 0.908 0.364
Muller et al 1982 1.053 0.942 1.178 0.912 0.362
Ghavimi et al 1982 1.060 0.953 1.180 1.077 0.281
Donaldson et al 1982 1.062 0.954 1.181 1.099 0.272
Hamaoui et al 1990 1.060 0.957 1.174 1.113 0.266
Von Meyenfeldt et al 1992 1.055 0.965 1.154 1.176 0.240
Smith et al 1992 1.059 0.970 1.157 1.285 0.199
Sandstrom et al 1993 1.052 0.972 1.139 1.258 0.208
Iovinelli et al 1993 1.070 0.991 1.156 1.733 0.083
Brennan et al 1994 1.065 0.992 1.143 1.735 0.083
Reynolds et al 1997 1.048 0.980 1.121 1.366 0.172
Bozzetti et al 2001 1.018 0.955 1.085 0.544 0.587
Kamei et al 2005 1.014 0.952 1.079 0.429 0.668
Liu et al 2011 1.015 0.956 1.078 0.498 0.618
Park et al 2012 1.006 0.949 1.067 0.197 0.843
Li et al 2015 1.011 0.956 1.071 0.392 0.695
Huang et al 2015 0.999 0.945 1.057 -0.034 0.973
0.999 0.945 1.057 -0.034 0.973
0.5 1 2
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Figure 5. No major complications for enteral nutrition (EN) and parenteral nutrition (PN) patients 
5.1 Analyses by EN – tube feeding and standard care 5.2 Analyses by nutrition status – protein 
energy malnutrition (PEM) and no PEM 5.3 Analyses by age of population – children and adults 
  
March 25, 2019 
This is a post-peer-review, pre-copyedit version of an article published in Supportive Care in Cancer.  
The final authenticated version is available online at: https://doi.org/10.1007/s00520-019-05145-w 
 
- 29 - 
 
Figure 6. No major complications for enteral (EN) and parenteral nutrition (PN) patients, over 
time 
  
Study name Cumulative statistics Cumulative mh risk ratio (95% CI)
Lower Upper 
Point limit limit Z-Value p-Value
Holter et al 1977 0.932 0.698 1.244 -0.478 0.632
Thompson et al 1981 0.979 0.777 1.232 -0.182 0.856
Sako et al 1981 0.980 0.821 1.169 -0.223 0.823
Lim et al 1981 0.952 0.802 1.131 -0.557 0.577
Muller et al 1982 0.909 0.787 1.051 -1.291 0.197
Von Meyenfeldt et al 1992 0.935 0.828 1.055 -1.094 0.274
Iovinelli et al 1993 0.959 0.862 1.066 -0.777 0.437
Brennan et al 1994 0.996 0.901 1.102 -0.071 0.943
Sand et al 1997 0.994 0.901 1.096 -0.130 0.897
Bozzetti et al 2001 1.010 0.926 1.103 0.231 0.818
Pacelli et al 2001 1.012 0.931 1.099 0.278 0.781
Aiko et al 2003 1.012 0.933 1.097 0.287 0.774
Fujita et al 2012 1.031 0.955 1.113 0.782 0.434
Klek et al 2014 1.029 0.956 1.108 0.766 0.444
Perinel et al 2016 1.018 0.946 1.095 0.467 0.640
1.018 0.946 1.095 0.467 0.640
0.5 1 2
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Figure 7. No mortality for enteral nutrition (EN) and parenteral nutrition (PN) patients 7.1 
Analyses by EN – tube feeding and standard care 7.2 Analyses by nutrition status – protein energy 
malnutrition (PEM) and no PEM 7.3 Analyses by age of population – children and adults 
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Figure 8. No mortality for enteral (EN) and parenteral nutrition (PN) patients, over time 
 
  
Study name Cumulative statistics Cumulative mh 
risk ratio (95% CI)Lower Upper 
Point limit limit Z-Value p-Value
Holter et al 1977 0.989 0.854 1.145 -0.148 0.882
van Eys et al 1980 1.008 0.879 1.155 0.111 0.912
Sako et al 1981 1.055 0.968 1.150 1.214 0.225
Lim et al 1981 1.043 0.960 1.134 1.001 0.317
Muller et al 1982 0.986 0.919 1.058 -0.400 0.689
Ghavimi et al 1982 0.986 0.919 1.057 -0.406 0.684
Donaldson et al 1982 0.987 0.924 1.056 -0.372 0.710
Hamaoui et al 1990 0.984 0.922 1.050 -0.498 0.619
Von Meyenfeldt et al 19920.976 0.924 1.030 -0.889 0.374
Smith et al 1992 0.974 0.923 1.027 -0.974 0.330
Sandstrom et al 1993 0.990 0.951 1.032 -0.458 0.647
Brennan et al 1994 1.004 0.969 1.041 0.226 0.821
Sand et al 1997 1.006 0.971 1.043 0.343 0.731
Reynolds et al 1997 1.002 0.969 1.036 0.128 0.898
Pacelli et al 2001 0.991 0.964 1.020 -0.598 0.550
Fujita et al 2012 0.993 0.969 1.017 -0.591 0.554
Klek et al 2014 0.991 0.971 1.013 -0.801 0.423
Harvey et al 2016 0.992 0.971 1.013 -0.750 0.453
Perinel et al 2016 0.987 0.967 1.007 -1.270 0.204
Chen et al 2017 0.989 0.970 1.009 -1.074 0.283
0.989 0.970 1.009 -1.074 0.283
0.5 1 2
Favours PN Favours EN
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Appendix 1. Search Strategy 
Database: Ovid MEDLINE(R) and Epub Ahead of Print, In-Process & Other Non-Indexed  
Citations, Daily and Versions(R) <1946 to December 20, 2018> Search Strategy: 
-------------------------------------------------------------------------------- 
1     exp Parenteral Nutrition/ (23169) 
2     exp Enteral Nutrition/ (18501) 
3     ((parenteral or intravenous*) adj2 (nutrition or feeding)).mp. (31068) 
4     ((enteral or enteric or tube or force) adj2 (nutrition or feeding)).mp. (26309) 
5     (1 or 3) and (2 or 4) (6209) 
6     exp Comparative Study/ (1815838) 
7     (comparison or comparative or compare* or versus or vs or match or rival* or oppose or "side 
by side" or alone or prefer* or better).mp. (6846615) 
8     or/6-7 (6846615) 
9     5 and 8 (2502) 
10     limit 9 to english language (2120) 




Database: Embase Classic+Embase <1947 to 2018 Week 51> Search Strategy: 
-------------------------------------------------------------------------------- 
1     exp parenteral nutrition/ (47926) 
2     exp enteric feeding/ (29141) 
3     ((parenteral or intravenous*) adj2 (nutrition or feeding)).mp. (49280) 
4     ((enteral or enteric or tube or force) adj2 (nutrition or feeding)).mp. (41156) 
5     (1 or 3) and (2 or 4) (10801) 
6     exp comparative study/ (1327146) 
7     (comparison or comparative or compare* or versus or vs or match or rival* or oppose or "side 
by side" or alone or prefer* or better).mp. (9108614) 
8     or/6-7 (9108614) 
9     5 and 8 (4130) 
10     limit 9 to english language (3499) 




Database: EBM Reviews - Cochrane Central Register of Controlled Trials <November 2018>  
Search Strategy: 
-------------------------------------------------------------------------------- 
1     exp Parenteral Nutrition/ (1554) 
2     exp Enteral Nutrition/ (1644) 
3     ((parenteral or intravenous*) adj2 (nutrition or feeding)).mp. (4161) 
4     ((enteral or enteric or tube or force) adj2 (nutrition or feeding)).mp. (4659) 
5     (1 or 3) and (2 or 4) (1653) 
6     exp Comparative Study/ (11) 
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7     (comparison or comparative or compare* or versus or vs or match or rival* or oppose or "side 
by side" or alone or prefer* or better).mp. (732365) 
8     or/6-7 (732365) 
9     5 and 8 (826) 
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Appendix 3. Assessment of risk of bias  
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Appendix 4. Assessment of publication bias for endpoint “No infection” 4.1 Assessment by 
enteral nutrition (EN) – tube feeding and standard care 4.2 Assessment by nutrition status – protein 
energy malnutrition (PEM) and PEM 4.3 Assessment by age of population – children and adults  
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Appendix 5. Assessment of publication bias for endpoint “No nutrition support complications” 
5.1 Assessment by enteral nutrition (EN) – tube feeding and standard care 5.2 Assessment by 
nutrition status – protein energy malnutrition (PEM) and PEM 5.3 Assessment by age of 
population – children and adults  
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Appendix 6. Assessment of publication bias for endpoint “No major complications” 6.1 
Assessment by enteral nutrition (EN) – tube feeding and standard care 6.2 Assessment by nutrition 
status – protein energy malnutrition (PEM) and PEM 6.3 Assessment by age of population – 
children and adults  
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Appendix 7. Assessment of publication bias for endpoint “No mortality” 7.1 Assessment by 
enteral nutrition (EN) – tube feeding and standard care 7.2 Assessment by nutrition status – protein 
energy malnutrition (PEM) and PEM 7.3 Assessment by age of population – children and adults  
